top of page
Writer's pictureCANNABIS ORCHARDS

Cannabis Orchards Receives Funding Support for Cutting-Edge Hemp Research on Polyploidy and Minor Cannabinoids

Updated: Aug 22

Kemptville, Ontario, August 8, 2024 – Cannabis Orchards Inc. is excited to announce that it is receiving funding totaling up to $600,305 from Agriculture and Agri-Food Canada’s AgriScience Program under the Sustainable Canadian Agricultural Partnership, and from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). This funding will support Cannabis Orchards’ innovative projects aimed at the genetic improvement of industrial hemp and the advancement of minor cannabinoid research.


The first non-repayable contribution of $404,305 from the AgriScience Program – Projects Component supports the project titled “Minor Cannabinoids, Major Advancements: Polyploidization and Enrichment of Cannabinoid Hemp,” with a total project cost of $808,610. This project aims to develop seedless triploid hemp lines for cannabidiol (CBD) and minor cannabinoids such as cannabigerol (CBG) and cannabichromene (CBC). Despite their therapeutic potential, minor cannabinoids remain rare in the market. By developing novel triploid hemp lines, Cannabis Orchards seeks to create new markets and maximize yields and profits for hemp farmers, providing them with enhanced minor cannabinoid hemp varieties capable of delivering novel cannabinoid profiles. These advancements will support the cannabinoid industry, enabling the production and supply of minor cannabinoids to both extractors and researchers, fueling commercialization opportunities in the recreational and medical markets, as well as research into therapeutic development.


Dr. Jamie Ghossein, CEO of Cannabis Orchards, commented, “The potential of minor cannabinoids in therapeutic applications is vast, yet they remain underutilized due to their scarcity. Our research and development efforts are dedicated to unlocking this potential, ultimately providing more effective treatment options for a variety of conditions and opening new commercialization opportunities for farmers and the Canadian cannabinoid industry.”


Through NRC IRAP, Cannabis Orchards is receiving advisory services and funding of up to  $196,000 supporting a research and development project titled, “Polyploidization for the Genetic Improvement of Industrial Hemp.” This project focuses on developing triploid hemp varieties through polyploidization, a process that creates plants with multiple sets of chromosomes. The primary objectives are to produce triploid hemp varieties and characterize their fertility and growth parameters. These advancements aim to enhance desirable traits in industrial hemp, such as increased biomass yield and cannabinoid content, while reducing the risk of unwanted cross-pollination by rendering plants infertile.


Dr. Ghossein added, “This support  from NRC IRAP will aide our cutting-edge research in polyploidy and hemp trait development. Our project will enable the development of seedless triploid hemp varieties, ensuring higher yields and more consistent quality for farmers and cannabinoid processors. By preventing unwanted pollination and enhancing desirable traits, we are paving the way for the next generation of industrial hemp genetics by maximizing yields for farmers and providing high-quality cannabinoid inputs to processors.”


Both projects commenced in early 2024 and will conclude by 2026, involving key activities such as minor cannabinoid hemp breeding, polyploidy experiments, fertility assessment, and field studies for characterization of physical traits and cannabinoid yields.


Contact Information:

Rachael Cranston

Sales Department

Cannabis Orchards


About Cannabis Orchards


Cannabis Orchards Inc. is an inventive, research-driven, and proudly Canadian company focused on furthering the development and commercialization of novel cannabinoids and therapeutics. The company leads research into the development of new hemp varieties with minor cannabinoid content and their applications in clinical settings. Cannabis Orchards’ products are highly sought after by Licensed Processors, research institutes, and pharmaceutical companies. For more information on Cannabis Orchards Inc., visit www.cannabisorchards.ca.

댓글


bottom of page